Resources

Pill Testing Australia Fact Sheet

02 September 2019

Report on the 2nd ACT GTM Pill Testing Pilot: a Harm Reduction Service

26 August 2019

Australia’s Annual Overdose Report 2019

26 August 2019

Australia’s Annual Overdose Report 2019 reveals that unintentional overdose continues to be a significant cause of death in Australia.

National Wastewater Drug Monitoring Program – Seventh Report

17 June 2019

The National Wastewater Drug Monitoring Program provides leading-edge, coordinated national research and intelligence on illicit drugs and licit drugs that can be abused, with a specific focus on methylamphetamine and other substances.

The Australian drug harms ranking study

13 May 2019

The aim of the current study was to review drug harms as they occur in Australia using the Multi-criteria Decision Analysis (MCDA) methodology adopted in earlier studies in other jurisdictions.

Out of the Shadows, Domestic and Family Violence: a leading cause of homelessness in Australia

11 April 2019

Domestic and family violence is a major driver of homelessness in Australia - particularly for women and their children. This position paper draws attention to the intersections between these issues, considers the evidence and puts forward recommendations for change. The best way of preventing homelessness as a result of domestic and family violence is to prevent the violence from occurring in the first place. This requires cultural and systemic change to change individual and community attitudes on gender and violence.

National Drug Strategy Household Survey 2016

28 September 2017

The National Drug Strategy Household Survey collects information from teenagers and adults across Australia. It asks what they think about tobacco, alcohol and other drugs; and about their use of these drugs.

Tasmanian Drug Trends 2017: Findings from the Illicit Drug Reporting System (IDRS)

The Illicit Drug Reporting System is an annual, national project designed to monitor data associated with the use of heroin, cocaine, methamphetamine and cannabis, in order that this information could act as an early warning indicator of the availability and use of these drugs.

Tasmanian Drug Strategy

The Tasmanian Drug Strategy (TDS) was developed by the Tasmanian Government, Department of Health and Human Services.

Tasmanian Drug Trends 2018: Key findings from the Illicit Drug Reporting System (IDRS) Interviews

This report summarises key findings from the 2018 Illicit Drug Reporting System interviews that were conducted in Hobart, Tasmania.

Tasmanian Trends in Ecstasy and Related Drug Markets 2018: Findings from the Ecstasy and Related Drugs Reporting System (EDRS)

This report summarises key findings from the 2018 Ecstasy and Related Drug Reporting System interviews that were conducted in Hobart, Tasmania.

Traditional Custodians.

The ATDC acknowledges the Tasmanian Aboriginal community as the traditional custodians of Tasmania and recognises the importance of working together.

Acknowledgements.

The ATDC gratefully acknowledges the financial and other support from the Australian Government Department of Health the Tasmanian Government Department of Health and the Tasmanian Health Service.

Quality Innovation Performance Accredited.

The ATDC is a Quality Innovation Performance (QIP) accredited organisation against the QIC Health and Community Services Standards 7th Edition.

Follow Us.

Twitter Facebook YouTube Email